Moore ML - Search Results

1

The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography.

Ke Z, Dillard RS, Chirkova T, Leon F, Stobart CC, Hampton CM, Strauss JD, Rajan D, Rostad CA, Taylor JV, Yi H, Shah R, Jin M, Hartert TV, Peebles RS Jr, Graham BS, Moore ML, Anderson LJ, Wright ER. Ke Z, et al. Among authors: moore ml. Viruses. 2018 Aug 20;10(8):446. doi: 10.3390/v10080446. Viruses. 2018. PMID: 30127286 Free PMC article.

2

RNA virus reverse genetics and vaccine design.

Stobart CC, Moore ML. Stobart CC, et al. Among authors: moore ml. Viruses. 2014 Jun 25;6(7):2531-50. doi: 10.3390/v6072531. Viruses. 2014. PMID: 24967693 Free PMC article. Review.

3

CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.

Chirkova T, Lin S, Oomens AGP, Gaston KA, Boyoglu-Barnum S, Meng J, Stobart CC, Cotton CU, Hartert TV, Moore ML, Ziady AG, Anderson LJ. Chirkova T, et al. Among authors: moore ml. J Gen Virol. 2015 Sep;96(9):2543-2556. doi: 10.1099/vir.0.000218. Epub 2015 Jun 25. J Gen Virol. 2015. PMID: 26297201 Free PMC article.

4

Reverse Genetics of Respiratory Syncytial Virus.

Stobart CC, Hotard AL, Meng J, Moore ML. Stobart CC, et al. Among authors: moore ml. Methods Mol Biol. 2016;1442:141-53. doi: 10.1007/978-1-4939-3687-8_10. Methods Mol Biol. 2016. PMID: 27464692

5

BAC-Based Recovery of Recombinant Respiratory Syncytial Virus (RSV).

Stobart CC, Hotard AL, Meng J, Moore ML. Stobart CC, et al. Among authors: moore ml. Methods Mol Biol. 2017;1602:111-124. doi: 10.1007/978-1-4939-6964-7_8. Methods Mol Biol. 2017. PMID: 28508217

6

Enhancing the Thermostability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Live-Attenuated Vaccine by Incorporating Unique RSV Line19F Protein Residues.

Rostad CA, Stobart CC, Todd SO, Molina SA, Lee S, Blanco JCG, Moore ML. Rostad CA, et al. Among authors: moore ml. J Virol. 2018 Feb 26;92(6):e01568-17. doi: 10.1128/JVI.01568-17. Print 2018 Mar 15. J Virol. 2018. PMID: 29263264 Free PMC article.

7

Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics.

Moore ML, Peebles RS Jr. Moore ML, et al. Pharmacol Ther. 2006 Nov;112(2):405-24. doi: 10.1016/j.pharmthera.2006.04.008. Epub 2006 Jul 3. Pharmacol Ther. 2006. PMID: 16820210 Review.

8

Respiratory syncytial virus and reactive airway disease.

Lotz MT, Moore ML, Peebles RS Jr. Lotz MT, et al. Among authors: moore ml. Curr Top Microbiol Immunol. 2013;372:105-18. doi: 10.1007/978-3-642-38919-1_5. Curr Top Microbiol Immunol. 2013. PMID: 24362686 Free PMC article.

9

Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective.

Boyoglu-Barnum S, Todd SO, Meng J, Barnum TR, Chirkova T, Haynes LM, Jadhao SJ, Tripp RA, Oomens AG, Moore ML, Anderson LJ. Boyoglu-Barnum S, et al. Among authors: moore ml. J Virol. 2017 Apr 28;91(10):e02059-16. doi: 10.1128/JVI.02059-16. Print 2017 May 15. J Virol. 2017. PMID: 28275196 Free PMC article.

10

Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection.

Numata M, Nagashima Y, Moore ML, Berry KZ, Chan M, Kandasamy P, Peebles RS Jr, Murphy RC, Voelker DR. Numata M, et al. Among authors: moore ml. J Lipid Res. 2013 Aug;54(8):2133-2143. doi: 10.1194/jlr.M037077. Epub 2013 Jun 6. J Lipid Res. 2013. PMID: 23749985 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

386 results

Search Page